Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...
In this article author Sachin Joglekar discusses the transformation of CLI terminals becoming agentic where developers can state goals while the AI agents plan, call tools, iterate, ask for approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback